Caffeine challenge and breath-holding duration in patients with panic disorder

Breath-holding (BH) has been used as a simple probe to increase endogenous carbon dioxide (CO 2). In patients with Panic Disorder (PD), lower baseline BH duration is associated with caffeine-induced panic attacks. In this paper, we assessed BH duration in PD patients in relation to panic attacks ind...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Progress in neuro-psychopharmacology & biological psychiatry 2009-02, Vol.33 (1), p.41-44
Hauptverfasser: Masdrakis, Vasilios G., Markianos, Manolis, Vaidakis, Nikolaos, Papakostas, Yiannis G., Oulis, Panagiotis
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 44
container_issue 1
container_start_page 41
container_title Progress in neuro-psychopharmacology & biological psychiatry
container_volume 33
creator Masdrakis, Vasilios G.
Markianos, Manolis
Vaidakis, Nikolaos
Papakostas, Yiannis G.
Oulis, Panagiotis
description Breath-holding (BH) has been used as a simple probe to increase endogenous carbon dioxide (CO 2). In patients with Panic Disorder (PD), lower baseline BH duration is associated with caffeine-induced panic attacks. In this paper, we assessed BH duration in PD patients in relation to panic attacks induced by caffeine intake. BH duration and state anxiety were assessed in 40 PD patients (12 males), both at baseline and after a 400-mg caffeine challenge test. Patients panicking after caffeine administration (14 patients, 4 males) exhibited a significant reduction of their post-challenge BH duration, while no change of the BH duration was observed in non-panicking patients (26 patients, 8 males). Reduction in post-challenge BH duration was not related to higher anxiety levels – as reflected in the State–Trait Anxiety Inventory-State Form scores – independently of the occurrence of a panic attack. Panickers exhibited significantly lower baseline BH duration, compared to non-panickers. Our findings indicate that in PD patients, caffeine-induced panic attacks are strongly associated with a significant reduction of BH duration at both pre- and post-challenge. Jointly, these findings suggest that in a subgroup of PD patients, sensitivity to endogenous CO 2 accumulation may underlie both the lower BH durations and the caffeine-induced panic attacks. In this subgroup of PD patients, caffeine might exert its panicogenic properties through the exacerbation of patients' already pathological hypersensitivity to CO 2 accumulation, as indicated by both the significant decrease of their BH duration at post-challenge and by their significantly lower baseline BH duration respectively.
doi_str_mv 10.1016/j.pnpbp.2008.10.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20394388</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584608003084</els_id><sourcerecordid>20394388</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-d36832446acd2d544bc90edcccbeb4e0e067c42b704da98d6b1a46fc45fecf9a3</originalsourceid><addsrcrecordid>eNp9kE1v2zAMhoWhxZpm-wUDBl-6m1PqI7Z82KEIurVA0F66syBTdKPAkT3JWdF_X2UJ1ttOJF88JIiHsS8cFhx4db1djGFsx4UA0DlZAIgPbMZ1rUsleHXGZiByv9SqumCXKW0BgEuQH9kF142Euq5n7GFlu458oAI3tu8pPFNhgyvaSHbalJuhdz48F24f7eSHUPhQjLmjMKXixU-bPAWPhfNpiI7iJ3be2T7R51Ods18_bp9Wd-X68ef96mZdouJ6Kp2stBRKVRadcEulWmyAHCK21CoCgqpGJdoalLONdlXLrao6VMuOsGusnLNvx7tjHH7vKU1m5xNS39tAwz4ZAbJRUusMyiOIcUgpUmfG6Hc2vhoO5qDRbM1fjeag8RBmjXnr6-n8vt2Re985ecvA1QmwCW3fRRvQp3-c4FzUdX5izr4fOcoy_niKJmGWh-R8JJyMG_x_H3kDbWuS-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20394388</pqid></control><display><type>article</type><title>Caffeine challenge and breath-holding duration in patients with panic disorder</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Masdrakis, Vasilios G. ; Markianos, Manolis ; Vaidakis, Nikolaos ; Papakostas, Yiannis G. ; Oulis, Panagiotis</creator><creatorcontrib>Masdrakis, Vasilios G. ; Markianos, Manolis ; Vaidakis, Nikolaos ; Papakostas, Yiannis G. ; Oulis, Panagiotis</creatorcontrib><description>Breath-holding (BH) has been used as a simple probe to increase endogenous carbon dioxide (CO 2). In patients with Panic Disorder (PD), lower baseline BH duration is associated with caffeine-induced panic attacks. In this paper, we assessed BH duration in PD patients in relation to panic attacks induced by caffeine intake. BH duration and state anxiety were assessed in 40 PD patients (12 males), both at baseline and after a 400-mg caffeine challenge test. Patients panicking after caffeine administration (14 patients, 4 males) exhibited a significant reduction of their post-challenge BH duration, while no change of the BH duration was observed in non-panicking patients (26 patients, 8 males). Reduction in post-challenge BH duration was not related to higher anxiety levels – as reflected in the State–Trait Anxiety Inventory-State Form scores – independently of the occurrence of a panic attack. Panickers exhibited significantly lower baseline BH duration, compared to non-panickers. Our findings indicate that in PD patients, caffeine-induced panic attacks are strongly associated with a significant reduction of BH duration at both pre- and post-challenge. Jointly, these findings suggest that in a subgroup of PD patients, sensitivity to endogenous CO 2 accumulation may underlie both the lower BH durations and the caffeine-induced panic attacks. In this subgroup of PD patients, caffeine might exert its panicogenic properties through the exacerbation of patients' already pathological hypersensitivity to CO 2 accumulation, as indicated by both the significant decrease of their BH duration at post-challenge and by their significantly lower baseline BH duration respectively.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2008.10.002</identifier><identifier>PMID: 18930777</identifier><identifier>CODEN: PNPPD7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adult ; Adult and adolescent clinical studies ; Anxiety disorders. Neuroses ; Asphyxia - metabolism ; Biological and medical sciences ; Breath-holding duration ; Caffeine - adverse effects ; Caffeine challenge test ; Carbon Dioxide - metabolism ; Female ; Humans ; Male ; Medical sciences ; Neuropharmacology ; Panic disorder ; Panic Disorder - chemically induced ; Panic Disorder - etiology ; Panic Disorder - physiopathology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychopharmacology ; Respiration</subject><ispartof>Progress in neuro-psychopharmacology &amp; biological psychiatry, 2009-02, Vol.33 (1), p.41-44</ispartof><rights>2008 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-d36832446acd2d544bc90edcccbeb4e0e067c42b704da98d6b1a46fc45fecf9a3</citedby><cites>FETCH-LOGICAL-c418t-d36832446acd2d544bc90edcccbeb4e0e067c42b704da98d6b1a46fc45fecf9a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pnpbp.2008.10.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21127720$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18930777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Masdrakis, Vasilios G.</creatorcontrib><creatorcontrib>Markianos, Manolis</creatorcontrib><creatorcontrib>Vaidakis, Nikolaos</creatorcontrib><creatorcontrib>Papakostas, Yiannis G.</creatorcontrib><creatorcontrib>Oulis, Panagiotis</creatorcontrib><title>Caffeine challenge and breath-holding duration in patients with panic disorder</title><title>Progress in neuro-psychopharmacology &amp; biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Breath-holding (BH) has been used as a simple probe to increase endogenous carbon dioxide (CO 2). In patients with Panic Disorder (PD), lower baseline BH duration is associated with caffeine-induced panic attacks. In this paper, we assessed BH duration in PD patients in relation to panic attacks induced by caffeine intake. BH duration and state anxiety were assessed in 40 PD patients (12 males), both at baseline and after a 400-mg caffeine challenge test. Patients panicking after caffeine administration (14 patients, 4 males) exhibited a significant reduction of their post-challenge BH duration, while no change of the BH duration was observed in non-panicking patients (26 patients, 8 males). Reduction in post-challenge BH duration was not related to higher anxiety levels – as reflected in the State–Trait Anxiety Inventory-State Form scores – independently of the occurrence of a panic attack. Panickers exhibited significantly lower baseline BH duration, compared to non-panickers. Our findings indicate that in PD patients, caffeine-induced panic attacks are strongly associated with a significant reduction of BH duration at both pre- and post-challenge. Jointly, these findings suggest that in a subgroup of PD patients, sensitivity to endogenous CO 2 accumulation may underlie both the lower BH durations and the caffeine-induced panic attacks. In this subgroup of PD patients, caffeine might exert its panicogenic properties through the exacerbation of patients' already pathological hypersensitivity to CO 2 accumulation, as indicated by both the significant decrease of their BH duration at post-challenge and by their significantly lower baseline BH duration respectively.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Anxiety disorders. Neuroses</subject><subject>Asphyxia - metabolism</subject><subject>Biological and medical sciences</subject><subject>Breath-holding duration</subject><subject>Caffeine - adverse effects</subject><subject>Caffeine challenge test</subject><subject>Carbon Dioxide - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Panic disorder</subject><subject>Panic Disorder - chemically induced</subject><subject>Panic Disorder - etiology</subject><subject>Panic Disorder - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Respiration</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v2zAMhoWhxZpm-wUDBl-6m1PqI7Z82KEIurVA0F66syBTdKPAkT3JWdF_X2UJ1ttOJF88JIiHsS8cFhx4db1djGFsx4UA0DlZAIgPbMZ1rUsleHXGZiByv9SqumCXKW0BgEuQH9kF142Euq5n7GFlu458oAI3tu8pPFNhgyvaSHbalJuhdz48F24f7eSHUPhQjLmjMKXixU-bPAWPhfNpiI7iJ3be2T7R51Ods18_bp9Wd-X68ef96mZdouJ6Kp2stBRKVRadcEulWmyAHCK21CoCgqpGJdoalLONdlXLrao6VMuOsGusnLNvx7tjHH7vKU1m5xNS39tAwz4ZAbJRUusMyiOIcUgpUmfG6Hc2vhoO5qDRbM1fjeag8RBmjXnr6-n8vt2Re985ecvA1QmwCW3fRRvQp3-c4FzUdX5izr4fOcoy_niKJmGWh-R8JJyMG_x_H3kDbWuS-A</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Masdrakis, Vasilios G.</creator><creator>Markianos, Manolis</creator><creator>Vaidakis, Nikolaos</creator><creator>Papakostas, Yiannis G.</creator><creator>Oulis, Panagiotis</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20090201</creationdate><title>Caffeine challenge and breath-holding duration in patients with panic disorder</title><author>Masdrakis, Vasilios G. ; Markianos, Manolis ; Vaidakis, Nikolaos ; Papakostas, Yiannis G. ; Oulis, Panagiotis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-d36832446acd2d544bc90edcccbeb4e0e067c42b704da98d6b1a46fc45fecf9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Anxiety disorders. Neuroses</topic><topic>Asphyxia - metabolism</topic><topic>Biological and medical sciences</topic><topic>Breath-holding duration</topic><topic>Caffeine - adverse effects</topic><topic>Caffeine challenge test</topic><topic>Carbon Dioxide - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Panic disorder</topic><topic>Panic Disorder - chemically induced</topic><topic>Panic Disorder - etiology</topic><topic>Panic Disorder - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Respiration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Masdrakis, Vasilios G.</creatorcontrib><creatorcontrib>Markianos, Manolis</creatorcontrib><creatorcontrib>Vaidakis, Nikolaos</creatorcontrib><creatorcontrib>Papakostas, Yiannis G.</creatorcontrib><creatorcontrib>Oulis, Panagiotis</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Masdrakis, Vasilios G.</au><au>Markianos, Manolis</au><au>Vaidakis, Nikolaos</au><au>Papakostas, Yiannis G.</au><au>Oulis, Panagiotis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Caffeine challenge and breath-holding duration in patients with panic disorder</atitle><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2009-02-01</date><risdate>2009</risdate><volume>33</volume><issue>1</issue><spage>41</spage><epage>44</epage><pages>41-44</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><coden>PNPPD7</coden><abstract>Breath-holding (BH) has been used as a simple probe to increase endogenous carbon dioxide (CO 2). In patients with Panic Disorder (PD), lower baseline BH duration is associated with caffeine-induced panic attacks. In this paper, we assessed BH duration in PD patients in relation to panic attacks induced by caffeine intake. BH duration and state anxiety were assessed in 40 PD patients (12 males), both at baseline and after a 400-mg caffeine challenge test. Patients panicking after caffeine administration (14 patients, 4 males) exhibited a significant reduction of their post-challenge BH duration, while no change of the BH duration was observed in non-panicking patients (26 patients, 8 males). Reduction in post-challenge BH duration was not related to higher anxiety levels – as reflected in the State–Trait Anxiety Inventory-State Form scores – independently of the occurrence of a panic attack. Panickers exhibited significantly lower baseline BH duration, compared to non-panickers. Our findings indicate that in PD patients, caffeine-induced panic attacks are strongly associated with a significant reduction of BH duration at both pre- and post-challenge. Jointly, these findings suggest that in a subgroup of PD patients, sensitivity to endogenous CO 2 accumulation may underlie both the lower BH durations and the caffeine-induced panic attacks. In this subgroup of PD patients, caffeine might exert its panicogenic properties through the exacerbation of patients' already pathological hypersensitivity to CO 2 accumulation, as indicated by both the significant decrease of their BH duration at post-challenge and by their significantly lower baseline BH duration respectively.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>18930777</pmid><doi>10.1016/j.pnpbp.2008.10.002</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0278-5846
ispartof Progress in neuro-psychopharmacology & biological psychiatry, 2009-02, Vol.33 (1), p.41-44
issn 0278-5846
1878-4216
language eng
recordid cdi_proquest_miscellaneous_20394388
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Adult and adolescent clinical studies
Anxiety disorders. Neuroses
Asphyxia - metabolism
Biological and medical sciences
Breath-holding duration
Caffeine - adverse effects
Caffeine challenge test
Carbon Dioxide - metabolism
Female
Humans
Male
Medical sciences
Neuropharmacology
Panic disorder
Panic Disorder - chemically induced
Panic Disorder - etiology
Panic Disorder - physiopathology
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychopharmacology
Respiration
title Caffeine challenge and breath-holding duration in patients with panic disorder
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A14%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Caffeine%20challenge%20and%20breath-holding%20duration%20in%20patients%20with%20panic%20disorder&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Masdrakis,%20Vasilios%20G.&rft.date=2009-02-01&rft.volume=33&rft.issue=1&rft.spage=41&rft.epage=44&rft.pages=41-44&rft.issn=0278-5846&rft.eissn=1878-4216&rft.coden=PNPPD7&rft_id=info:doi/10.1016/j.pnpbp.2008.10.002&rft_dat=%3Cproquest_cross%3E20394388%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20394388&rft_id=info:pmid/18930777&rft_els_id=S0278584608003084&rfr_iscdi=true